TickerTalks
Browse all tickers →
TickerTalks›$NHI
NHNHI

National Health Investors, Inc.

$NHI·$3.6B·REIT - Healthcare Facilities·Real Estate
$72.95+2.4%1Y-1.8%
Mentions · last 7 days
2026-08-07: 2 posts2026-08-08: 0 posts2026-08-09: 0 posts2026-08-10: 7 posts2026-08-11: 2 posts2026-08-12: 1 posts2026-08-13: 0 posts12-8%
Price updated 5h ago·X counts updated 1d ago
NHNHI
$NHINational Health Investors, Inc.
$72.95+2.36%12 posts-8%
AI analysisFundamentalsVoices on X
Loading…

AI verdict & sentimentAI analysisGenerated by AI from underlying data

Today's AI verdict on what's driving $NHI, plus how loud the X conversation is and which way it's leaning.

AI analysis

TickerTalks’ read on the fundamentals and what’s driving the move.

Proven numbersWinding up for a moveAI verdict · as of 2026-08-14

Trading in a tight range and building pressure — a move looks likely soon, but the direction isn't clear yet.

National Health Investors Q2 FFO lagged estimates — 5.3% yield on the earnings dip, senior-housing operator concentration remains the swing factor.

NHI's four-quarter revenue $90M → $107M → $116M → $121M with EPS $0.69 → $0.80 → $0.83 → $1.15 — the sequential ramp reflects Bickford senior-housing operator transitions and lease-modification pass-throughs; Q2 FFO lagged sell-side estimates per the wire.

  • Consensus FY26 revenue $284M / EPS $3.75 walking to $282M / $3.28 FY27 and $275M / $3.51 FY28 (2–3 analysts) — flat revenue with EPS dip in FY27 likely reflects modeled lease/interest recomputation; AFFO/share is the more relevant metric for a REIT.
  • The 'Buy the Earnings Dip and Lock In a 5.3% Yield' framing captures the tension — Q2 was operationally soft but the yield is intact; debt/equity reported at 0 reflects consolidated accounting quirks, not zero leverage.
  • -4% over 12 months, position 14% of 52-week range, -5% below 50-day and -10% below 200-day MA, beta 0.56, float 47.3M — bombed vs 52-week peak on the FFO miss, tape working off a low base.

Next print 2026-11-05 is where operator lease-payment collections, senior-housing occupancy commentary, and dividend commentary either extend the recovery or expose that Q2 was the sign of deeper operator stress.

What to watch: November 5 Q3 print — Bickford / other operator lease-collection status, senior-housing occupancy, updated FY26 AFFO/share, dividend commentary, and any refinancing announcements.

On the calendar: 2026-11-05 — Q3 2026 earnings

Read the AI verdict + X sentiment for $NHI

  • One-line verdict on what's driving the move — fundamentals, momentum, both, or an event
  • Next dated catalyst when there is one (earnings, deal closing, activist clock)
  • X crowd read with bullish/bearish call + post volume
Free, forever. No credit card.

What it does

Plain-English summary of the business — what they sell and how they make money.

Healthcare REIT financing senior living and medical facilities through sale-leaseback and mortgage structures across the US.

Industry overviewAI analysisGenerated by AI from underlying data

Where REIT - Healthcare Facilities sits in its cycle right now — and what that implies for $NHI.

REIT - Healthcare Facilities · Real Estate

No material change from last week — the Silver Tsunami accelerating in 2026 as the oldest boomers reach 80 creates a durable multi-year demand runway for senior housing and memory care capacity.

Industry benchmark

4-name peer basket
+20.3%YTD
+24.5%1Y

Fundamentals & catalyst

Profitability, valuation, and the next earnings event — at a glance, with rule-of-thumb signals.

Key ratios

P/E
21.4How much investors are paying per dollar of profit the company actually earned in the last 12 months. Lower means the stock looks cheaper relative to earnings.~15–25 is typical for the S&P 500; high-growth names trade 30+; hyper-growth or speculative can be 100+ or negative.
ROIC
4.7%What percentage return the business earns on every dollar of capital (equity + debt) deployed in operations. The cleanest measure of business quality.Above ~15% is high-quality; consistently above 25% suggests a real moat. Below the company's cost of capital is value-destroying.
Op margin
33.9%Operating profit (after sales, marketing, R&D, and overhead but before interest and taxes) as a percentage of revenue. The clearest view of how well the underlying business is run.Mature business above 20% is healthy; software businesses can run 30%+; commodity / retail businesses operate in single digits.
FCF yield
6.5%Free cash flow (operating cash flow minus capex) divided by the company's market cap. The cash-on-cash return you'd get owning the whole business at today's price.Above ~5% is attractive; below ~2% means you're paying up for growth. Capital-light businesses (software) run higher than capital-heavy ones (utilities).
P/S
8.3Same idea as P/E but per dollar of revenue. Useful for companies that aren't profitable yet, where P/E is meaningless.Under ~2 is cheap; software / SaaS often runs 8–15; well above 20 implies the market is pricing in very high future growth.
ROE
11.0%Net income as a percentage of shareholders' equity. Similar to ROIC but counts only the equity side.Above 20% is strong, but can be inflated by leverage — a heavily indebted company can show high ROE with weak underlying ROIC.
Gross margin
36.7%Revenue minus the direct cost of producing what was sold, as a percentage of revenue. The first read on whether the product is structurally profitable.Software / SaaS is typically 70%+; consumer goods 30–50%; commodity / hardware businesses can be under 20%.
D/E
0.0Total debt divided by shareholders' equity. Measures how much the business runs on borrowed money versus owner capital.Under 1 is conservative; 1–2 is typical for mature businesses; over 2 is leveraged and more sensitive to interest rates.

Past earnings

QuarterReportedActualEstimateSurprise
Q2 2026Aug 10, 2026$1.19$0.84+41.2%
Q1 2026May 4, 2026$0.83$1.21-31.4%
Q4 2025Feb 26, 2026$1.22$0.80+52.3%
Q3 2025Nov 6, 2025$1.32$1.24+6.5%
Next earningsThu, Nov 5·consensus EPS $1.15

Quarterly trend

QuarterRevenueYoYGrossOpEPSFCF
Q2 FY26$121.3M+33.8%0.0%0.1%$1.15$67.9M
Q1 FY26$115.9M+29.7%31.1%45.2%$0.83$50.5M
Q4 FY25$106.5M+24.2%33.6%47.2%$0.80$59.3M
Q3 FY25$89.8M+8.3%97.1%49.1%$0.69$57.6M

Forward consensus

5-year forecast · up to 3 analysts
FYRevenueRangeEPSRangeAnalysts
FY26$283.9M$276.8M – $294.5M$3.75$3.67 – $3.913
FY27$282.3M$275.2M – $292.8M$3.28$3.21 – $3.373
FY28$274.7M$261.9M – $287.6M$3.51$3.49 – $3.542
FY29$302.3M$294.8M – $313.6M$0.00$0.00 – $0.001
FY30$307.1M$299.5M – $318.6M$0.00$0.00 – $0.001

Setup & momentum

Volume, range, and moving-average position — the technical setup driving short-term moves.

Right now

Vol vs 30dToday's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.0.9×Today's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.
52w rangeWhere the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.14%Where the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.
vs 50d MALatest close vs the 50-day simple moving average. Positive = short-term trend is up.-5.0%Latest close vs the 50-day simple moving average. Positive = short-term trend is up.
vs 200d MALatest close vs the 200-day simple moving average. Positive = long-term trend is up.-9.5%Latest close vs the 200-day simple moving average. Positive = long-term trend is up.

Float & profile

FloatLow float · 47.3M shFree-float shares — the slice of issued stock actually available to trade. Lower buckets squeeze harder on a catalyst.Traded today0.8% of floatToday's volume as a percent of the free float. Above 5% on a single day is unusually high turnover for the available share count.β0.565-year weekly beta vs the S&P 500. Above 1.5 means the stock typically moves more than the index; below 0.8 moves less.

Insider activity

Recent open-market buys and sells by officers and directors — flagged when multiple insiders cluster.

Recent transactions

BuyJun 15Robert A MccabeDirector890 sh$64KBuyJun 5Mendelsohn D. EricCEO1.5K sh$103K
+ 32 other (14 awards · 11 inkinds · 6 exempts · 1 gift) in window

See when $NHI insiders are putting their own money in

  • Real-time open-market buys and sells from Form 4 filings
  • Cluster-buy detection when multiple insiders pile in at once
  • 30 / 60 / 180-day windows so you can spot building conviction
Free, forever. No credit card.

SEC filings

Material 8-K, 13D, S-3, and 424B5 events from the last 180 days — the filings that actually move the price.

Recent material filings

8-KPress release / Reg FDAug 108-K — Item 7.01: Press release / Reg FD
AI summary

National Health Investors (NHI) filed an 8-K on August 11, 2026 under Item 7.01 (Regulation FD), furnishing an investor presentation simultaneously made public. The excerpt is the cover page; the presentation is in the exhibit. NHI is a healthcare REIT investing in senior housing and skilled nursing facilities. This is the first of two Reg FD filings by NHI on the same date, likely reflecting updated materials for an investor conference or roadshow.

8-KPress release / Reg FDAug 108-K — Item 7.01: Press release / Reg FD
AI summary

National Health Investors (NHI) filed a second 8-K on August 11, 2026 under Item 7.01 (Regulation FD), furnishing additional investor materials alongside its Q2 2026 earnings release. The excerpt is the cover page; the actual materials are in the exhibit. This appears to be a supplemental disclosure package (e.g., data supplement or updated investor deck) filed concurrently with the first Reg FD 8-K and the Q2 earnings 8-K on the same date.

3New insider — initial holdingsJul 303
AI summary

Christian Ken Maingot filed a Form 3 on July 31, 2026 (event date July 27), reporting his initial beneficial ownership of securities in National Health Investors (NHI) as Chief Operating Officer. The filing indicates no securities are owned at the time of filing. NHI is a healthcare REIT investing in senior housing and skilled nursing facilities. Future equity awards to Maingot in his COO role will be disclosed on Form 4.

8-KOfficer or director changeJul 278-K — Item 5.02: Officer or director change
AI summary

National Health Investors (NHI) filed an 8-K on July 28, 2026 (event date July 22) under Item 5.02, reporting a change in its officers or directors. The excerpt is the cover page; the specific officer identity and transition details are in the body. NHI is a healthcare REIT; this July officer change is separate from the concurrent appointment of Christian Maingot as COO (Form 3 filed July 31). Leadership transitions at REITs are monitored for their impact on capital allocation and property strategy.

3New insider — initial holdingsJul 23
AI summary

Todd Michael Siefert filed a Form 3 on July 3, 2026 (event date July 1), reporting his initial beneficial ownership of National Health Investors (NHI) as Chief Financial Officer. He holds 3,048 shares directly, plus stock options to acquire 16,666 shares at $71.76 per share (vesting schedule TBD) and additional option grants. The stock options signal his compensation package includes equity-linked performance incentives. NHI is a healthcare REIT investing in senior housing and skilled nursing properties.

8-KAgreement terminatedJul 18-K — Item 1.02: Agreement terminated · Item 2.01: Acquisition completed
AI summary

National Health Investors (NHI) filed an 8-K on July 2, 2026 (event date July 1) under Items 1.02 and 2.01, reporting the termination of a material agreement (1.02) and the completion of an acquisition or disposition of assets (2.01). The combination of 1.02 and 2.01 strongly suggests NHI sold or divested a property or portfolio, terminating the related lease or management agreement upon disposition. NHI is a healthcare REIT; asset sales are routine portfolio management for REITs optimizing their property mix.

8-KOfficer or director changeJul 18-K — Item 5.02: Officer or director change
AI summary

National Health Investors (NHI) filed an 8-K on July 2, 2026 (event date July 1) under Item 5.02, reporting a change in its officers or directors. The excerpt is the cover page; the specific officer identity and transition details are in the body. This officer change 8-K was filed the same day as the NHI asset sale 8-K (Job 146), suggesting concurrent leadership and portfolio management activity. NHI is a healthcare REIT.

8-KShareholder voteMay 298-K — Item 5.07: Shareholder vote
+ 29 other (8 8-Ks · 5 13Gs · 3 earnings 8-Ks · 2 10-Qs) in window

Recent news

Latest headlines from major outlets, sourced and timestamped — context for whatever just moved.

PEB or NHI: Which Is the Better Value Stock Right Now?zacks.com·13h agoNational Health Investors: Buy The Earnings Dip And Lock In A 5.3% Yieldseekingalpha.com·3d agoNational Health Investors Q2 Earnings Call Highlightsmarketbeat.com·3d agoNational Health Investors, Inc. (NHI) Q2 2026 Earnings Call Transcriptseekingalpha.com·4d agoNational Health Investors (NHI) Q2 FFO Lag Estimateszacks.com·4d ago

More in REIT - Healthcare Facilities

Peers in the same group — one click to compare setups, fundamentals, and chatter.

$LTC$WELL$DOC$AHR$SBRA
Voices on X · last 7 days

No standout posts about $NHI on X in the last 7 days.

TickerTalks is a research tool, not financial advice. We surface social-attention data; we do not make stock recommendations. Past attention is not predictive of future price movements.

PrivacyTermsSupport